These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 35605973)
1. Biomarker Candidates for Tumors Identified from Deep-Profiled Plasma Stem Predominantly from the Low Abundant Area. Tognetti M; Sklodowski K; Müller S; Kamber D; Muntel J; Bruderer R; Reiter L J Proteome Res; 2022 Jul; 21(7):1718-1735. PubMed ID: 35605973 [TBL] [Abstract][Full Text] [Related]
2. Analysis of 1508 Plasma Samples by Capillary-Flow Data-Independent Acquisition Profiles Proteomics of Weight Loss and Maintenance. Bruderer R; Muntel J; Müller S; Bernhardt OM; Gandhi T; Cominetti O; Macron C; Carayol J; Rinner O; Astrup A; Saris WHM; Hager J; Valsesia A; Dayon L; Reiter L Mol Cell Proteomics; 2019 Jun; 18(6):1242-1254. PubMed ID: 30948622 [TBL] [Abstract][Full Text] [Related]
3. Protein alterations associated with pancreatic cancer and chronic pancreatitis found in human plasma using global quantitative proteomics profiling. Pan S; Chen R; Crispin DA; May D; Stevens T; McIntosh MW; Bronner MP; Ziogas A; Anton-Culver H; Brentnall TA J Proteome Res; 2011 May; 10(5):2359-76. PubMed ID: 21443201 [TBL] [Abstract][Full Text] [Related]
5. Absolute Quantification of All Identified Plasma Proteins from SWATH Data for Biomarker Discovery. Rice SJ; Liu X; Zhang J; Belani CP Proteomics; 2019 Feb; 19(3):e1800135. PubMed ID: 30585401 [TBL] [Abstract][Full Text] [Related]
6. Use of a Recombinant Biomarker Protein DDA Library Increases DIA Coverage of Low Abundance Plasma Proteins. Ahn SB; Kamath KS; Mohamedali A; Noor Z; Wu JX; Pascovici D; Adhikari S; Cheruku HR; Guillemin GJ; McKay MJ; Nice EC; Baker MS J Proteome Res; 2021 May; 20(5):2374-2389. PubMed ID: 33752330 [TBL] [Abstract][Full Text] [Related]
7. High-throughput, in-depth and estimated absolute quantification of plasma proteome using data-independent acquisition/mass spectrometry ("HIAP-DIA"). Zhou Y; Tan Z; Xue P; Wang Y; Li X; Guan F Proteomics; 2021 Mar; 21(5):e2000264. PubMed ID: 33460299 [TBL] [Abstract][Full Text] [Related]
8. Mixed-mode ion exchange-based integrated proteomics technology for fast and deep plasma proteome profiling. Xue L; Lin L; Zhou W; Chen W; Tang J; Sun X; Huang P; Tian R J Chromatogr A; 2018 Aug; 1564():76-84. PubMed ID: 29935814 [TBL] [Abstract][Full Text] [Related]
9. Plasma Biomarker Identification and Quantification by Microparticle Proteomics. Harel M; Geiger T Methods Mol Biol; 2017; 1619():477-486. PubMed ID: 28674905 [TBL] [Abstract][Full Text] [Related]
10. Proteomics of microparticles with SILAC Quantification (PROMIS-Quan): a novel proteomic method for plasma biomarker quantification. Harel M; Oren-Giladi P; Kaidar-Person O; Shaked Y; Geiger T Mol Cell Proteomics; 2015 Apr; 14(4):1127-36. PubMed ID: 25624350 [TBL] [Abstract][Full Text] [Related]
11. Establishment and clinical application evaluations of a deep mining strategy of plasma proteomics based on nanomaterial protein coronas. Wang J; Xie W; Sun L; Li J; Wu S; Li R; Zhao Y Anal Chim Acta; 2023 Sep; 1275():341569. PubMed ID: 37524462 [TBL] [Abstract][Full Text] [Related]
12. Quantitative Proteomics Based on Optimized Data-Independent Acquisition in Plasma Analysis. Nigjeh EN; Chen R; Brand RE; Petersen GM; Chari ST; von Haller PD; Eng JK; Feng Z; Yan Q; Brentnall TA; Pan S J Proteome Res; 2017 Feb; 16(2):665-676. PubMed ID: 27995795 [TBL] [Abstract][Full Text] [Related]
13. Integrated proteomic sample preparation with combination of on-line high-abundance protein depletion, denaturation, reduction, desalting and digestion to achieve high throughput plasma proteome quantification. Li Y; Yuan H; Dai Z; Zhang W; Zhang X; Zhao B; Liang Z; Zhang L; Zhang Y Anal Chim Acta; 2021 Apr; 1154():338343. PubMed ID: 33736814 [TBL] [Abstract][Full Text] [Related]
14. Label-free plasma proteomics for the identification of the putative biomarkers of oral squamous cell carcinoma. Gautam SS; Singh RP; Karsauliya K; Sonker AK; Reddy PJ; Mehrotra D; Gupta S; Singh S; Kumar R; Singh SP J Proteomics; 2022 May; 259():104541. PubMed ID: 35231661 [TBL] [Abstract][Full Text] [Related]
15. Emerging Affinity-Based Proteomic Technologies for Large-Scale Plasma Profiling in Cardiovascular Disease. Smith JG; Gerszten RE Circulation; 2017 Apr; 135(17):1651-1664. PubMed ID: 28438806 [TBL] [Abstract][Full Text] [Related]
16. SWATH Mass Spectrometry for Proteomics of Non-Depleted Plasma. Krisp C; Molloy MP Methods Mol Biol; 2017; 1619():373-383. PubMed ID: 28674897 [TBL] [Abstract][Full Text] [Related]
17. Data independent acquisition of plasma biomarkers of response to neoadjuvant chemotherapy in pancreatic ductal adenocarcinoma. O'Rourke MB; Sahni S; Samra J; Mittal A; Molloy MP J Proteomics; 2021 Jan; 231():103998. PubMed ID: 33027703 [TBL] [Abstract][Full Text] [Related]
18. Label-free proteomics reveals serum proteins whose levels differ between pancreatic ductal adenocarcinoma patients with short or long survival. Holm M; Saraswat M; Joenväärä S; Seppänen H; Renkonen R; Haglund C Tumour Biol; 2020 Jun; 42(6):1010428320936410. PubMed ID: 32586207 [TBL] [Abstract][Full Text] [Related]
19. Direct Assessment of Plasma/Serum Sample Quality for Proteomics Biomarker Investigation. Greco V; Piras C; Pieroni L; Urbani A Methods Mol Biol; 2017; 1619():3-21. PubMed ID: 28674873 [TBL] [Abstract][Full Text] [Related]
20. Leveraging homologies for cross-species plasma proteomics in ungulates using data-independent acquisition. Noor Z; Paramasivan S; Ghodasara P; Chemonges S; Gupta R; Kopp S; Mills PC; Ranganathan S; Satake N; Sadowski P J Proteomics; 2022 Jan; 250():104384. PubMed ID: 34601153 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]